# Can 5-Amino-1MQ improve metabolic aging and insulin sensitivity?

Canonical source: https://retacompare.com/research/can-5-amino-1mq-improve-metabolic-aging-and-insulin-sensitivity

Peptide Longevity Q&A · 2021-03-01


    Research indicates that 5-Amino-1MQ, through its action on nicotinamide N-methyltransferase (NNMT), may influence metabolic aging and insulin sensitivity by regulating cellular metabolism and epigenetic gene expression linked to obesity and insulin resistance.

 What the research shows

The study focuses on nicotinamide N-methyltransferase (NNMT), an enzyme that plays a significant role in cellular metabolism and epigenetic regulation. NNMT catalyzes the methylation of nicotinamide using S-adenosyl methionine, linking one-carbon metabolism to a cell's methylation balance and levels of nicotinamide adenine dinucleotide (NAD+). The research highlights how NNMT's expression is tissue-specific and can have both beneficial and detrimental effects, particularly in the context of obesity and insulin resistance. Increased NNMT levels have been associated with various cancers, suggesting a complex role in metabolism and disease.

 Why it matters for longevity

Understanding the role of NNMT in metabolic aging is crucial as it connects energy metabolism with gene regulation. The enzyme's involvement in obesity and insulin resistance indicates that targeting NNMT could be a potential strategy for improving metabolic health in aging populations. By modulating NNMT activity, it may be possible to enhance insulin sensitivity and overall metabolic function, which are vital for maintaining healthspan and longevity.

 Key findings at a glance

NNMT is a metabolic enzyme that influences both metabolism and epigenetic regulation.

Its activity is linked to the methylation balance and NAD+ levels in cells.

NNMT expression varies by tissue type and can affect health positively or negatively.

Higher NNMT levels are associated with obesity, insulin resistance, and certain cancers.

Targeting NNMT may offer therapeutic avenues for metabolic disorders and cancer.

 How 5-Amino-1MQ works (background)

5-Amino-1MQ functions as an inhibitor of NNMT, potentially altering the enzyme's activity to favor metabolic health. By inhibiting NNMT, 5-Amino-1MQ may help restore the balance of methylation processes and improve NAD+ levels, which are critical for energy metabolism. This mechanism suggests that 5-Amino-1MQ could play a role in mitigating the effects of metabolic aging and enhancing insulin sensitivity, thereby supporting healthier aging.

 Safety, caveats, and what we don't yet know

While the research presents promising insights into the role of NNMT and 5-Amino-1MQ, it is essential to approach these findings with caution. The effects of 5-Amino-1MQ in human populations are not fully understood, and further studies are needed to evaluate its safety, efficacy, and potential side effects. Additionally, the specific populations that may benefit from 5-Amino-1MQ have yet to be thoroughly investigated, leaving gaps in knowledge regarding its application in diverse demographic groups.

 Bottom line

5-Amino-1MQ may influence metabolic aging and insulin sensitivity through its action on NNMT, which is linked to cellular metabolism and epigenetic regulation. Further research is necessary to clarify its potential benefits and applications.

 Related questions

 How does 5-Amino-1MQ affect energy metabolism?

5-Amino-1MQ may enhance energy metabolism by inhibiting NNMT, which is involved in the regulation of NAD+ levels and methylation processes critical for cellular energy balance.

 Can 5-Amino-1MQ help with obesity management?

Research suggests that by targeting NNMT, 5-Amino-1MQ may help address metabolic issues related to obesity, potentially improving insulin sensitivity and metabolic health.

 What are the potential side effects of 5-Amino-1MQ?

While specific side effects of 5-Amino-1MQ are not well-documented, ongoing research is needed to assess its safety and any adverse effects in human populations.

 Source: PubMed · Mol Metab · published 2021-03-01.

## Sources

- PubMed · Mol Metab: https://pubmed.ncbi.nlm.nih.gov/33453420/